nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absorption, Distribution, and Binding Profile of ME-401, a Potent and Selective Oral Small-Molecule Inhibitor of Phosphatidylinositol 3-Kinase δ (PI3Kδ) in Animal and B-Cell Lymphoma Models
|
Moreno, Ofir |
|
2019 |
14 |
5 |
p. 603-611 |
artikel |
2 |
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
|
Monica, Silvia La |
|
2019 |
14 |
5 |
p. 619-626 |
artikel |
3 |
A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors
|
Karasic, Thomas B. |
|
2019 |
14 |
5 |
p. 613-618 |
artikel |
4 |
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
|
Mokdad, Ali A. |
|
2019 |
14 |
5 |
p. 541-550 |
artikel |
5 |
Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial
|
Shore, Neal |
|
2019 |
14 |
5 |
p. 527-539 |
artikel |
6 |
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
|
Kim, Sung-Bae |
|
2019 |
14 |
5 |
p. 591-601 |
artikel |
7 |
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current State
|
Grivas, Petros |
|
2019 |
14 |
5 |
p. 505-525 |
artikel |
8 |
Inhibition of Aurora A Kinase in Combination with Chemotherapy Induces Synthetic Lethality and Overcomes Chemoresistance in Myc-Overexpressing Lymphoma
|
Park, Steven I. |
|
2019 |
14 |
5 |
p. 563-575 |
artikel |
9 |
Plasma B-Cell Maturation Antigen Levels are Elevated and Correlate with Disease Activity in Patients with Chronic Lymphocytic Leukemia
|
Udd, Kyle A. |
|
2019 |
14 |
5 |
p. 551-561 |
artikel |
10 |
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX)
|
Liewen, Heike |
|
2019 |
14 |
5 |
p. 577-590 |
artikel |
11 |
Venetoclax: A Review in Relapsed/Refractory Chronic Lymphocytic Leukemia
|
Scott, Lesley J. |
|
2019 |
14 |
5 |
p. 493-504 |
artikel |